Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2014

May 13, 2014

30339_dirs_2014-05-13_d2fd2b76-4c46-40fe-8ca0-a3442980855a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2014-05-09

Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-05-09 Common Stock A 29.4900 $43.0400 Acquired 24059.7442 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 850776.7332 Direct
Common Stock 2693.6600 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.